Early myocardial fibrosis is associated with depletion of vasoactive intestinal peptide in rat heart

Experimental Physiology

Volumn 87, Issue 5, 2002, Pages 539-546

  Ye, Victor Z C ^a   Hodge, George ^a   Yong, James L C ^a   Duggan, Karen A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; HEART MUSCLE FIBROSIS; HISTOLOGY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN DEPLETION; RAT; SODIUM INTAKE; SODIUM RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE LEVEL;

EID: 0036712037     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/eph8702335     Document Type: Article

References (37)

1. VIP and NPY in canine hearts. Distribution and effect of total and selective parasympathetic denervation
2. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: Comparison with isoproterenol and forskolin
3. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart
4. Regression of myocardial fibrosis in hypertensive heart disease: Diverse effects of various antihypertensive drugs
5. Reactive and reparative myocardial fibrosis in arterial hypertension
6. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure
7. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneous hypertensive rat
8. Vasoactive intestinal peptide fluctuates in human blood with a circadian rhythm
9. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit
10. Vasoactive intestinal peptide and pituitary adenyl cyclase-activating peptide inhibit endotoxin-induced TNF-alpha production by macrophages: In vitro and in vivo studies
11. Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit
12. Sodium depletion decreases VIP metabolism in the rabbit
13. VIP: A direct renal natriuretic substance
14. Effect of treatment with enalapril on the metabolism and tissue concentrations of vasoactive intestinal peptide
15. Effects of endopeptidase 24.11 blockade on plasma and tissue concentrations of vasoactive intestinal peptide
16. Reversal of cardiac hypertrophy and fibrosis by S12402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in the SHR
17. Relationship between dietary sodium intake, haemodynamics and cardiac mass in SHR and WKY rats
18. Peptide-containing nerve fibres in guinea-pig coronary arteries: Immunohistochemistry, ultrastructure and vasomotility
19. Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide
20. Acute but not chronic gastric sodium administration regulates vasoactive intestinal peptide metabolism by the liver
21. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat
22. Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham study
23. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium
24. Cardiac response to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations
25. Altered signal transduction system in hypertrophied myocardium: Angiotensin II stimulates collagen synthesis in hypertrophied hearts
26. The neutral endopeptidase inhibitor, SCH34826 reduces left ventricular hypertrophy in spontaneously hypertensive rats
27. Effect of vasoactive intestinal peptide on isolated perfused rat kidney
28. Polypeptide with broad biological activity: Isolation from small intestine
29. Vasoactive intestinal peptide evokes endothelium dependent relaxation and cyclic AMP accumulation in rat aorta
30. Effect of vasoactive intestinal peptide (VIP) on cyclic AMP level and relaxation in rat isolated aorta
31. Vasoactive intestinal peptide (VIP) inhibits TGF-beta I production in murine macrophages
32. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition
33. Transforming growth factor beta-1 in acute myocardial infarction in rats
34. Human and canine ventricular vasoactive intestinal polypeptide: Decrease with heart failure
35. Vasoactive intestinal peptide downregulates the intrahepatic renin-angiotensin system in the rat
36. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats
37. Dietary sodium intake and left ventricular hypertrophy in normotensive rats